Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.
U.S. ‘industrial renaissance’ is fueling a rebound in fundraising, Apollo CEO Marc Rowan says
Capital raising activity is set for a rebound in the U.S. amid a global “industrial renaissance,” Oaktree Capital Management Co-Chairman Howard Marks says.